» Articles » PMID: 36702144

Understanding and Managing Patients with Overlapping Disorders of Gut-brain Interaction

Overview
Specialty Gastroenterology
Date 2023 Jan 26
PMID 36702144
Authors
Affiliations
Soon will be listed here.
Abstract

Disorders of gut-brain interaction (DGBI) are frequently encountered in clinical practice, and recommendations for diagnosis and management are well established. In a large subset of patients, more than one DGBI diagnosis is present. This group of patients with more than one DGBI diagnosis have higher symptom severity and impact than patients with only one DGBI diagnosis, and the management approach is not well established for those with overlapping diagnoses. This Review aims to guide clinicians to understand, recognise, and manage overlapping DGBI by identifying causes and pitfalls of overlap conditions, and presenting potential practical approaches to diagnosis, treatment, and follow-up. Several clinical factors can contribute to finding overlapping DGBI, including the anatomical basis of the Rome diagnostic criteria, the potential confusion of symptom descriptors, and patients' biases towards higher symptom intensity ratings. Overlapping DGBI could also be caused by mechanistic factors such as pathophysiological mechanisms involving multiple gastrointestinal segments, and the effect of disorders in one segment on sensorimotor function in remote gastrointestinal parts, through neural or hormonal signalling. Key initial steps in the management of overlapping DGBI are detailed history taking, which can be facilitated using pictograms; carefully assessing the relative timing and cohesion of different symptoms; and recognising associated psychosocial dysfunction. Unnecessary technical investigations and complex combination treatment schedules should be avoided. Based on the identification of the dominant symptom pattern and putative underlying pathophysiological mechanisms, a single treatment modality should preferably be initiated, considering the efficacy spectrum of different therapies. Follow-up of the patient's condition allows the therapeutic approach to be adjusted as needed, while avoiding unnecessary additional technical investigations.

Citing Articles

Rome Foundation Working Team Report on overlap in disorders of gut-brain interaction.

Barbara G, Aziz I, Ballou S, Chang L, Ford A, Fukudo S Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39870943 DOI: 10.1038/s41575-024-01033-9.


Causal atlas between inflammatory bowel disease and mental disorders: a bi-directional 2-sample Mendelian randomization study.

Yang X, Yang L, Zhang T, Zhang H, Chen H, Zuo X Front Immunol. 2023; 14:1267834.

PMID: 37901213 PMC: 10611497. DOI: 10.3389/fimmu.2023.1267834.


Combined GWAS and single cell transcriptomics uncover the underlying genes and cell types in disorders of gut-brain interaction.

Majd A, Richter M, Samuel R, Cesiulis A, Ghazizadeh Z, Wang J medRxiv. 2023; .

PMID: 37333423 PMC: 10275016. DOI: 10.1101/2023.06.02.23290906.

References
1.
Van Oudenhove L, Tornblom H, Storsrud S, Tack J, Simren M . Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome. Gastroenterology. 2015; 150(4):866-74. DOI: 10.1053/j.gastro.2015.11.010. View

2.
Peghini P, Katz P, Castell D . Imipramine decreases oesophageal pain perception in human male volunteers. Gut. 1998; 42(6):807-13. PMC: 1727141. DOI: 10.1136/gut.42.6.807. View

3.
Burns G, Carroll G, Mathe A, Horvat J, Foster P, Walker M . Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Am J Gastroenterol. 2019; 114(3):429-436. DOI: 10.1038/s41395-018-0377-0. View

4.
Pauwels A, Altan E, Tack J . The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro-esophageal reflux disease. Neurogastroenterol Motil. 2014; 26(4):581-8. DOI: 10.1111/nmo.12305. View

5.
Piche T, Zerbib F, Varannes S, Cherbut C, Anini Y, Roze C . Modulation by colonic fermentation of LES function in humans. Am J Physiol Gastrointest Liver Physiol. 2000; 278(4):G578-84. DOI: 10.1152/ajpgi.2000.278.4.G578. View